Страна: Тайван
Език: китайски
Източник: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
HUMAN PLASMA PROTEIN THEREOF IMMUNOGLOBULIN G(IgG) ≧96% WITH ANTIBODIES TO CYTOMEGALOVIRUS 100U
禾利行股份有限公司 台北市松山區敦化北路311號3樓 (03126405)
J06B
注射劑
HUMAN PLASMA PROTEIN THEREOF IMMUNOGLOBULIN G(IgG) ≧96% WITH ANTIBODIES TO CYTOMEGALOVIRUS 100U (1600002100) (IgG的比例約為65%IgG1, 30%IgG2, 3%IgG3, 2%IgG4。IgA於成品中的含量不大於2mg/ml)MG
瓶裝
菌 疫
限由醫師使用
BIOTEST PHARM GMBH LANDSTEINER STRABE 5, D-63303 DREIEICH,WEST GERMANY DE
IMMUNOGLOBULINS
移植或用免疫抑制劑治療時預防巨細胞病毒之感染
有效日期: 2029/07/17; 英文品名: CYTOTECT CP BIOTEST
2014-06-25
“䔼⋆”㑻⟘䄷㮦⫂㱰 CYTOTECT CP BIOTEST 圙丰劊䑩巶⨕䧪 000285 唝 㗪咣攎䏯恩⳩Ḽ䏦 1. ౢࠔӜᆀ Cytotect CP Biotest 2. ᏊໆϷಔԋ ΓᜪѮಒझੰࢥխࣝౚೈқ (CMVIG) 1ml ݙᏊ֖Ǻ Human plasma protein 50mg (immunoglobulin G ԿϿ՞ 96% а ) Ϸ antibodies against cytomegalovirus (CMV) 100U* Ƕ *Paul-Ehrlich-Institute (PEI) ୖԵྗࠔޑൂՏǶ 10 ml ֖ԖǺΓᜪՈዀೈқ 500 mg (immunoglobulin G ԿϿэ 96% а ) ϷלѮಒझੰࢥ (CMV) לᡏ 1,000U Ƕ 50 ml ֖ԖǺΓᜪՈዀೈқ 2,500 mg (immunoglobulin G ԿϿэ 96% а ) ϷלѮಒझੰࢥ (CMV) לᡏ 5,000U Ƕ IgG ޑКٯऊࣁ ( εऊኧॶ ) Ǻ IgG1 65% IgG2 30% IgG3 3% IgG4 2% IgA ܭԋࠔύޑ֖ໆόεܭ 2,000 micrograms/ml Ƕ җΓᜪਈᜄՈዀᇙഢǶ ၁ಒ፟Ꮚፎୖ᎙ 6.1 Ƕ 3. Ꮚ ࠠ ݙనᏊ ዂమ܈༾٢қϷคՅ܈܈ՅྋనǴ pH ॶ 5.0-5.6 ᆶᅖᓸ 250-350 mOsm/kg Ƕ 4. ᖏ၁ಒၗ 4.1 ᔈੱ ౽܈ҔխࣝڋᏊݯᕍਔႣٛѮಒझੰࢥϐགࢉǶ 4.2 ҔݤϷҔໆ Ҕ ໆ ൂᏊໆࣁϦАᡏख़ᆶ 1 డϲҁౢࠔǶ ӧՉ౽Ϻᔈ໒ۈᆶҁࠔǶჹମᡎ౽ੰΓǴӧ౽ 10 Ϻё໒ۈ ϒҁࠔբࣁႣٛҔǴձࢂӧ CMV Ոమ܄ޑੰΓǶҁࠔᔈ 2 Կ 3 ຼϒԛǴӅीϒԿϿ 6 ঁൂᏊໆǶ ࠸ู _ _ ٽูکߙϿԃ (0-18 ྃ ) ޑҔໆᆶԋԃΓޑҔໆค౦ǶჹܭᅿᔈੱǴ֡٩ ᡏख़๏ۓǴ٠ਥᏵॊᖏ่݀ՉፓǶ طфૈόӄ _ _ ҞคᏵᡉҢࢂցፓᏊໆǶ фૈόӄ ନᖏाѦόፓᏊໆǴፎୖ᎙ _4.4_ Ƕ _ _ ԃߏޣ ନᖏाѦόፓᏊໆǴፎୖ᎙ 4.4 Ƕ ϒ৩ ᓉેᒡݙ٬ҔǶ Cytotect CP Biotest ᔈаᓉેᒡݙϒǴଆۈޑᒡݙೲ 0.08 ml/ ϦАᡏख़ / λਔǴԿϿ 10 ϩដǶፎୖ᎙ 4.4 ǶऩวғόؼϸᔈǴѸफ़եᛰೲࡋ ܈ଶЗᒡݙǶऩऐڙ܄ؼӳ߾ёᄌᄌቚуԿ 0.8 ml/ ϦА / λਔǶ 4.3 䠿⺊䒅 x ⫋‴ ᳹ノᶻᵸⲦ䯮侜 䒃㪐䑩䋁喉䔻 (HUMAN CYTOMEGALOVIRUS IMMUNOGLOBULIN)⊈‴⃕㑺 6.1 䩾室⸠⅏弌㐍仃 Прочетете целия документ